See more : Magellan Gold Corporation (MAGE) Income Statement Analysis – Financial Results
Complete financial analysis of So-Young International Inc. (SY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of So-Young International Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Oriental Carbon & Chemicals Limited (ORIENTCQ.BO) Income Statement Analysis – Financial Results
- Concert Pharmaceuticals, Inc. (CNCE) Income Statement Analysis – Financial Results
- Meta Materials Inc. (MMTLP) Income Statement Analysis – Financial Results
- Mahanagar Telephone Nigam Limited (MTNL.BO) Income Statement Analysis – Financial Results
- SABB Takaful Company (8080.SR) Income Statement Analysis – Financial Results
So-Young International Inc. (SY)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.soyoung.com
About So-Young International Inc.
So-Young International Inc. operates an online platform for medical aesthetics and consumption healthcare services focusing on discretionary medical treatments in the People's Republic of China and internationally. Its platform enables users to discover content and share their own experience on medical aesthetics procedures and leads users to reserve treatment services from medical aesthetic service providers for offline treatment. The company facilitates research on medical aesthetic treatment trends; ratings and reviews on treatment experiences; and blogs under the name Beauty Diaries. It also provides reservation services in the areas of dermatology, dentistry and orthodontics, ophthalmology, physical examinations, gynecology, human papilloma virus vaccines, and postnatal care; Software as a Service; and guiding and consulting services through training programs for medical service providers. In addition, the company offers internet information and technology advisory, management consulting, and Internet culture services, as well as sells medical equipment; equipment production, sales, and agency services; and micro finance services. As of December 31, 2021, it had approximately 8,400 medical aesthetic service providers and 5,000 other consumption healthcare service providers on its platform. The company was founded in 2013 and is headquartered in Beijing, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.50B | 1.26B | 1.69B | 1.29B | 1.15B | 617.23M | 259.31M | 49.09M |
| Cost of Revenue | 544.34M | 393.29M | 327.89M | 212.21M | 198.63M | 91.56M | 44.80M | 25.19M |
| Gross Profit | 953.69M | 864.58M | 1.36B | 1.08B | 953.01M | 525.66M | 214.51M | 23.90M |
| Gross Profit Ratio | 63.66% | 68.73% | 80.63% | 83.61% | 82.75% | 85.17% | 82.72% | 48.68% |
| Research & Development | 203.52M | 235.09M | 286.57M | 229.19M | 177.27M | 94.73M | 32.56M | 17.93M |
| General & Administrative | 290.77M | 260.21M | 252.21M | 183.99M | 160.53M | 75.44M | 29.73M | 18.04M |
| Selling & Marketing | 520.45M | 472.09M | 792.48M | 726.30M | 470.03M | 306.36M | 127.46M | 62.21M |
| SG&A | 811.22M | 732.30M | 1.04B | 910.28M | 630.56M | 381.80M | 157.19M | 80.25M |
| Other Expenses | 0.00 | 8.25M | 12.04M | 8.92M | 34.78M | 990.00K | -12.22M | -203.00K |
| Operating Expenses | 1.01B | 967.39M | 1.33B | 1.14B | 807.83M | 476.53M | 189.74M | 98.18M |
| Cost & Expenses | 1.56B | 1.36B | 1.66B | 1.35B | 1.01B | 568.09M | 234.54M | 123.37M |
| Interest Income | 48.84M | 28.88M | 19.33M | 39.67M | 45.05M | 10.88M | 176.00K | 507.00K |
| Interest Expense | 0.00 | 28.88M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 46.09M | 47.09M | 30.08M | 14.09M | 6.13M | 1.67M | 619.00K | 564.00K |
| EBITDA | -14.96M | -55.72M | 63.39M | -42.61M | 151.30M | 50.80M | 25.38M | -73.72M |
| EBITDA Ratio | -1.00% | -7.84% | 6.67% | -5.34% | 12.48% | 8.68% | 8.11% | -149.34% |
| Operating Income | -61.05M | -102.81M | 82.79M | -56.69M | 145.18M | 49.14M | 24.76M | -74.28M |
| Operating Income Ratio | -4.08% | -8.17% | 4.89% | -4.38% | 12.61% | 7.96% | 9.55% | -151.32% |
| Total Other Income/Expenses | 68.92M | 15.73M | 16.17M | 56.79M | 81.28M | 9.12M | -11.54M | -6.75M |
| Income Before Tax | 7.87M | -87.07M | -16.41M | 93.00K | 226.46M | 58.25M | 13.22M | -81.04M |
| Income Before Tax Ratio | 0.53% | -6.92% | -0.97% | 0.01% | 19.66% | 9.44% | 5.10% | -165.08% |
| Income Tax Expense | -18.08M | -20.97M | 21.23M | -4.78M | 49.74M | 3.17M | -3.98M | -100.00K |
| Net Income | 21.28M | -66.11M | -37.64M | 5.81M | 176.72M | 55.08M | 17.20M | -81.04M |
| Net Income Ratio | 1.42% | -5.26% | -2.22% | 0.45% | 15.35% | 8.92% | 6.63% | -165.08% |
| EPS | 0.21 | -0.62 | -0.35 | 0.05 | 2.29 | 1.73 | -0.32 | -0.97 |
| EPS Diluted | 0.21 | -0.62 | -0.35 | 0.05 | 2.15 | 1.73 | -0.32 | -0.94 |
| Weighted Avg Shares Out | 102.46M | 106.18M | 106.18M | 106.00M | 82.23M | 31.92M | 34.95M | 83.13M |
| Weighted Avg Shares Out (Dil) | 101.47M | 106.18M | 106.18M | 108.92M | 82.30M | 31.92M | 34.95M | 86.49M |
So-Young International Inc. (SY) Q4 2023 Earnings Call Transcript
So-Young Reports Unaudited Fourth Quarter and Fiscal Year 2023 Financial Results
So-Young to Report Fourth Quarter and Full Year 2023 Financial Results on March 20, 2024
So-Young Announces Update on Repurchase and Cancellation of Shares
Grant of Restricted Share Units to Mr. Xing Jin
So-Young Enters into Strategic Partnership with Healtech to Further Expand Supply Chain Business
So-Young International Inc. (SY) Q3 2023 Earnings Call Transcript
So-Young Reports Unaudited Third Quarter 2023 Financial Results
So-Young's Subsidiary Wuhan Miracle Submits Application Documents for Initial Public Offering on China's Beijing Stock Exchange
So-Young to Report Third Quarter 2023 Financial Results on November 20, 2023
Source: https://incomestatements.info
Category: Stock Reports